age-related%20macular%20degeneration
AGE-RELATED MACULAR DEGENERATION
Age-related macular degeneration is a common, chronic, progressive, degenerative disease that causes central loss of vision due to abnormalities that occurs in the pigment, neural and vascular layers of the macula.
The macular disorder may have one or more of the following:
- Formation of drusen which are localized deposits of extracellular material usually concentrated in the macula
- Abnormalities in the retinal pigment epithelium (eg hypopigmentation or hyperpigmentation)
- Retinal pigment epithelium and choriocapillaris geographic atrophy
- Neovascular (exudative) maculopathy
Decreased central vision and distortion of seeing straight lines are the most common symptoms.

Age-related%20macular%20degeneration Patient Education

Patient Education

  • Instruct patients with age-related macular degeneration (AMD) on how to test their vision daily or at least weekly
    • While patients with exudative AMD or have had laser treatment, should be instructed on how to monitor the size of their blind spots or the appearance of new ones
  • Encourage high risk patients (eg with early AMD and/or family history of AMD) to have regular dilated eye exams for the early detection of the intermediate stage of AMD
  • For low risk patients, it is recommended to have comprehensive medical eye evaluation schedule as below:
    • Patients 40-54 years old every 2-4 years
    • Patients 55-64 years old every 1-3 years
    • Patients ≥65 years old every 1-2 years
  • Patients should be informed about the symptoms of progressing choroidal neovascularization (CNV) (eg progressive decrease in central vision) and counsel on the need for prompt consultation with an ophthalmologist
  • Smoking cessation should be done as this is the main modifiable risk factor for AMD
  • Diet that includes leafy green vegetables, fresh fruits and fishes rich in omega-3 fatty acids may help decrease the risk for AMD
  • Maintain an ideal body weight
    • Increased body mass index (BMI) and abdominal obesity have increased risk for AMD
  • Wear sunglasses with 100% protection against ultraviolet A and B (UVA and UVB) radiation in bright environments
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 2 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.
4 days ago
Osteoarthritis (OA) is the most common condition affecting the joints. Dr Lee Eu Jin, an Orthopaedic Surgeon from Liberty Orthopaedic Clinic at Mount Elizabeth Medical Centre, Singapore, shares his insights with Pearl Toh on how to manage OA in the primary care setting.


3 days ago
XOFLUZA – Baloxavir marboxil 20 mg and 40 mg FC tab